Keywords: Ascorbic acid (VitC); Soluble epoxide hydrolase (sEH); Epoxyeicosatrienoic acids (EETs); Dihydroxyeicosatrienoic acids (DHETs); Downregulation;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: AD; Alzheimer's disease; ARA; arachidonic acid; COX; cyclooxygenase; CYP450; cytochrome P450; DHA; docosahexaenoic acid; EPA; eicosapentaenoic acid; EETs; epoxyeicosatrienoic acids; EpFAs; epoxy-fatty acids; ER Stress; endoplasmic reticulum stress; IBD; i
Keywords: Rhizoma Coptidis; Soluble epoxide hydrolase (sEH); Anti-inflammation; Eicosanoids; Cytokines;
Keywords: Aloe; Anthraquinone derivatives; Soluble epoxide hydrolase (sEH); Molecular simulation
Keywords: Omega-3 fatty acids; Epoxy fatty acids (EpFAs); Epoxyeicosatrienoic acids (EETs); Epoxydocosapentanoic acids (EDP; EpDPEs); Soluble epoxide hydrolase (sEH); Pain
Novel piperidine-derived amide sEH inhibitors as mediators of lipid metabolism with improved stability
Keywords: Soluble epoxide hydrolase (sEH); Non-urea sEH inhibitors; Liver microsomal stability assay; Structure activity relationship (SAR) study; Isosteres;
Soluble epoxide hydrolase inhibition alleviates neuropathy in Akita (Ins2 Akita) mice
Keywords: Soluble epoxide hydrolase (sEH); Epoxy-fatty acid (EpFA); Anti-nociception; Chronic pain; Diabetic neuropathy;
In vitro inhibitory effects of ethanol extract of Danshen (Salvia miltiorrhiza) and its components on the catalytic activity of soluble epoxide hydrolase
Keywords: Danshen (Salvia miltiorrhiza); Soluble epoxide hydrolase (sEH); Inhibitor; Tanshinone IIA; Cryptotanshinone; Salvianolic acid C
Synthesis and biological evaluation of sorafenib- and regorafenib-like sEH inhibitors
Keywords: HCC; hepatocellular carcinoma; RCC; renal cell carcinoma; GI50; concentration required to inhibit cell growth by 50%; EpFAs; epoxygenated fatty acids; t-CUPM; trans-4-{4-[3-(4-chloro-3-trifluoromethyl-phenyl)-ureido]-cyclohexyloxy}-pyridine-2-carboxylic a
Development of a semi-automated LC/MS/MS method for the simultaneous quantitation of 14,15-epoxyeicosatrienoic acid, 14,15-dihydroxyeicosatrienoic acid, leukotoxin and leukotoxin diol in human plasma as biomarkers of soluble epoxide hydrolase activity in
Keywords: Soluble epoxide hydrolase (sEH); Epoxyeicosatrienoic acid (EET); Dihydroxyeicosatrienoic acid (DHET); Epoxyoctadec-12(Z)-enoic acid (leukotoxin); Dihydroxyoctadec-12(Z)-enoic acid (leukotoxin diol); LC/MS; Quantitation; Human plasma
Design of bioavailable derivatives of 12-(3-adamantan-1-yl-ureido)dodecanoic acid, a potent inhibitor of the soluble epoxide hydrolase
Keywords: Soluble epoxide hydrolase (sEH); sEH inhibitors; 1,3-disubstituted ureas; Pharmacokinetic properties